I agree that this site is using cookies. You can find further informations here.
X
Recker, David
114  results:
Search for persons X
?
1

606 A RANDOMIZED PARALLEL-GROUP STUDY OF SELF-ADMINISTERED,..:

Berry, Rani ; Berry, Sameer K. ; Recker, David...
Gastroenterology.  164 (2023)  6 - p. S-112-S-113 , 2023
Link: https://doi.org/10.1016/..
 
?
2

Matrix-Applied Characterized Autologous Cultured Chondrocyt..:

Brittberg, Mats ; Recker, David ; Ilgenfritz, John..
The American Journal of Sports Medicine.  46 (2018)  6 - p. 1343-1351 , 2018
Link: https://doi.org/10.1177/..
 
?
3

The ixCELL-DCM Trial: Rationale and Design:

Henry, Timothy D. ; Schaer, Gary L. ; Demaria, Anthony...
Cell Transplantation.  25 (2016)  9 - p. 1689-1699 , 2016
Link: https://doi.org/10.3727/..
 
?
4

Lack of an Effect of a Novel β3-Adrenoceptor Agonist, TAK-6..:

Redman, Leanne M. ; de Jonge, Lilian ; Fang, Xiaobing...
The Journal of Clinical Endocrinology & Metabolism.  92 (2006)  2 - p. 527-531 , 2006
Link: https://doi.org/10.1210/..
 
?
5

Identification and partial purification of a protein bindin..:

Gimble, Jeffrey M. ; Flanagan, James R. ; Recker, David.
Nucleic Acids Research.  16 (1988)  11 - p. 4967-4988 , 1988
Link: https://doi.org/10.1093/..
 
?
6

Twenty-Five Years' Experience and Beyond with Cultured Epid..:

Hickerson, William L ; Remmers, Ann E ; Recker, David P
Journal of Burn Care & Research.  40 (2018)  2 - p. 157-165 , 2018
Link: https://doi.org/10.1093/..
 
?
7

The COX-2 Selective Inhibitor, Valdecoxib, Does Not Impair ..:

Leese, Philip T. ; Recker, David P. ; Kent, Jeffrey D.
Journal of Clinical Pharmacology.  43 (2003)  5 - p. 504-513 , 2003
Link: https://doi.org/10.1177/..
 
?
8

A selective inhibitor of inducible nitric oxide synthase in..:

Hansel, Trevor T. ; Kharitonov, Sergei A. ; Donnelly, Louise E....
The FASEB Journal.  17 (2003)  10 - p. 1298-1300 , 2003
Link: https://doi.org/10.1096/..
 
?
9

The COX-2 Specific Inhibitor, Valdecoxib, Is An Effective, ..:

Reynolds, Lowell W ; Hoo, Robert K ; Brill, Robert J...
Journal of Pain and Symptom Management.  25 (2003)  2 - p. 133-141 , 2003
Link: https://doi.org/10.1016/..
 
?
10

The COX‐2 Selective Inhibitor, Valdecoxib, Does Not Impair ..:

Leese, Philip T. ; Recker, David P. ; Kent, Jeffrey D.
The Journal of Clinical Pharmacology.  43 (2003)  5 - p. 504-513 , 2003
Link: https://doi.org/10.1177/..
 
?
11

Efficacy and safety of the COX-2 specific inhibitor valdeco..:

Makarowski, W. ; Zhao, William W. ; Bevirt, Terry.
Osteoarthritis and Cartilage.  10 (2002)  4 - p. 290-296 , 2002
Link: https://doi.org/10.1053/..
 
?
12

A Single Preoperative Oral Dose of Valdecoxib, a New Cycloo..:

Desjardins, Paul J. ; Shu, Vincent S. ; Recker, David P...
Anesthesiology.  97 (2002)  3 - p. 565-573 , 2002
Link: https://doi.org/10.1097/..
 
?
13

Valdecoxib does not impair platelet function:

Leese, Philip T. ; Talwalker, Sheela ; Kent, Jeffrey D..
The American Journal of Emergency Medicine.  20 (2002)  4 - p. 275-281 , 2002
Link: https://doi.org/10.1053/..
 
?
14

Valdecoxib, a Cyclooxygenase-2-Specific Inhibitor, Is Effec..:

Daniels, Stephen E. ; Talwalker, Sheela ; Torri, Sarah...
Obstetrics & Gynecology.  100 (2002)  2 - p. 350-358 , 2002
Link: https://doi.org/10.1097/..
 
?
15

Reduced incidence of gastroduodenal ulcers with valdecoxib ..:

Goldstein, Jay L. ; Fakouhi, Kaffa M. ; Zhao, William W....
Gastroenterology.  120 (2001)  5 - p. A597 , 2001
Link: https://doi.org/10.1016/..
 
1-15